Skip to content

Drug interactions

Levoketoconazole + Repaglinide

Severity: Major

Levoketoconazole and Repaglinide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Levoketoconazole is a strong CYP3A4 inhibitor and can markedly raise repaglinide levels. This increases the risk of prolonged hypoglycemia.

What this interaction means in plain words

Levoketoconazole and Repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Levoketoconazole belongs to Endocrine; Repaglinide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Levoketoconazole strongly inhibits CYP3A4, reducing repaglinide metabolism.

What to do

Avoid the combination if possible and choose another antidiabetic agent. If unavoidable, reduce the repaglinide dose and monitor glucose closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Levoketoconazole and Repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Levoketoconazole with Repaglinide?

MediHelp rates the interaction as major. Levoketoconazole and Repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Levoketoconazole is a strong CYP3A4 inhibitor and can markedly raise repaglinide levels. This increases the risk of prolonged hypoglycemia.

How serious is the interaction between Levoketoconazole and Repaglinide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible and choose another antidiabetic agent. If unavoidable, reduce the repaglinide dose and monitor glucose closely.

What other medicines interact with Repaglinide?

MediHelp also lists interactions of Repaglinide with, for example, Gemfibrozil, Clarithromycin, Clopidogrel. The full list is on the Repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in